Beryl Drugs (BOM:524606) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524606 Beryl Drugs Ltd BOM:524606
71 GF Score
Price ₹24.59
GF Value ₹25.15
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Beryl Drugs FFO per Share?

FFO per Share only applies to REITs.

BOM:524606
71GF Score
Beryl Drugs Ltd BOM:524606
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beryl Drugs (BOM:524606) Overvalued in 2026?

Based on GuruFocus' analysis, Beryl Drugs stock appears to be undervalued. The current stock price of ₹24.59 is trading 2.2% below its estimated GF Value™ of ₹25.15. GuruFocus considers Beryl Drugs to be Fairly Valued.

Key valuation signals for BOM:524606:

  • FFO per Share:
  • GF Value™: ₹25.15 vs. price of ₹24.59 (2.2% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the BOM:524606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Beryl Drugs Business Description

Address 133, Kanchan Bagh, Ground Floor, Indore, MP, IND, 452001
Beryl Drugs Ltd is a pharmaceutical company principally engaged in the manufacturing and marketing of allopathic pharmaceutical preparations. It also provides contract manufacturing services and veterinary products. It offers manufacturing options for product requirements like small-volume injectables in liquid form, small-volume injectables in dry powder form, eye and ear drops, intravenous fluids in poly pack and glass bottles, and veterinary medicines. The company earns the majority of its revenue from the sale of Bulk Drugs.
71GF Score

Get the complete analysis for BOM:524606

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹24.59
Price
₹25.15
GF Value